Luba Greenwood

Luba Greenwood

Direktor/Vorstandsmitglied bei IN8BIO, INC.

Vermögen: 9 090 $ am 31.07.2026

47 Jahre
Health Technology
Finance
Consumer Services

Profil

Luba Greenwood was the founder of LUCA Biologics, Inc., founded in 2019, serving as Chief Executive Officer & Director from 2019 to 2021.
Ms. Greenwood is also the founder of Pharma Digital Health Roundtable.
Current positions include Non-Executive Director at Abcam Ltd. (United Kingdom) since 2022; Director at Massachusetts Biotechnology Council; Director at Entrinsic, Inc. (Massachusetts); Director at Scinapsis Analytics, Inc. since 2021; Independent Director at Os Acquisition Corp.
since 2021; Independent Director at IN8bio, Inc. since 2021; Professor at Harvard University since 2019; Advisor at CHV Management LLC; Managing Partner at Dana-Farber, Inc.; Advisor at Van Leer Xenia Ventures; Senior Advisor at Grove Ventures Capital (GP) Ltd.; Member at Massachusetts Board of Bar Overseers; Advisor at Stuff That Works Ltd. since 2021; Managing Partner at Binney Street Capital since 2020; Managing Partner at Cathay Capital Private Equity SAS. Former positions include Director at IRX Therapeutics, Inc.; Director at Longwood Symphony Orchestra, Inc. in 2016; Directors at Brooklyn Immunotherapeutics Investors LP from 2017 to 2022; Director at Kojin Therapeutics, Inc. in 2021; Director at Ernexa Therapeutics, Inc. from 2021 to 2022; Director at Traws Pharma, Inc. in 2024; Senior Counsel at Pfizer Inc. from 2011 to 2014; VP-Global Business Development at F.
Hoffmann-La Roche Ltd. from 2015 to 2018; Executive Managing Partner at Dana-Farber Cancer Institute, Inc. from 2019 to 2024; VP-Global Business Development & Mergers at Roche Holding AG from 2015 to 2018; Venture Partner at Colt Ventures Ltd. in 2015; Vice President at Axcella Health, Inc. from 2014 to 2015; Head-Strategic Business Development at Verily Life Sciences LLC from 2018 to 2019; Managing Partner at The Cathay Capital Group; Senior Associate at WilmerHale LLP from 2004 to 2011.
Education includes undergraduate degree from Brandeis University and graduate degree from Northeastern University School of Law.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
09.05.2026 8’783 ( 0.09% ) 9 090 $ 31.07.2026

Aktive Positionen von Luba Greenwood

UnternehmenPositionBeginn
IN8BIO, INC. Direktor/Vorstandsmitglied 01.07.2021
ABCAM PLC Direktor/Vorstandsmitglied 12.09.2022
Berater -
Corporate Officer/Principal 01.06.2019
Corporate Officer/Principal -
Berater 01.01.2021
Berater -
Berater -
Private Equity Investor -
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Luba Greenwood

UnternehmenPositionEnde
░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ -
Sehen Sie sich die Erfahrung von Luba Greenwood im Detail an

Ausbildung von Luba Greenwood

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

72

Beziehungen ersten Grades

34

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Finance

Commercial Services

Finance

Finance

Health Technology

Consumer Services

Finance

Technology Services

Technology Services

Finance

Technology Services

Commercial Services

Health Technology

Finance

The Cathay Capital Group

Health Technology

Health Technology

Technology Services

Finance

Health Technology

Finance

Pharma Digital Health Roundtable

Commercial Services

Consumer Services

  1. Börse
  2. Insiders
  3. Luba Greenwood